Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
Kyung Sik Park, Yeong Seok Lee, Heo Won Park, Sang Hyuck Seo, Byung Guk Jang, Jun Young Hwang, Kwang Bum Cho, Jae Seok Hwang, Sung Hoon Ahn, Yu Na Kang, Gap Chul Kim
Korean J Intern Med. 2004;19(1):19-26.   Published online 2004 Mar 1     DOI: https://doi.org/10.3904/kjim.2004.19.1.19
Citations to this article as recorded by Crossref logo
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A. Harrison, Elizabeth M. Brunt, Arun J. Sanyal
Hepatology.2018; 67(1): 328.     CrossRef
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
Mazen Noureddin, Aarshi Vipani, Catherine Bresee, Tsuyoshi Todo, Irene K. Kim, Naim Alkhouri, Veronica Wendy Setiawan, Tram Tran, Walid S. Ayoub, Shelly C. Lu, Andrew S. Klein, Vinay Sundaram, Nicholas N. Nissen
American Journal of Gastroenterology.2018; 113(11): 1649.     CrossRef
Thrombocytopenia as a marker of liver steatosis in a low-endemic area for schistosomiasis mansoni
Alba Otoni, Carlos Mauricio de Figueiredo Antunes, Fernanda Ferreira Tavares, Débora Heloísa Quadros Araújo, Thiago de Almeida Pereira, Leonardo Campos de Queiroz, Frederico Figueiredo Amâncio, José Roberto Lambertucci
Revista da Associação Médica Brasileira.2017; 63(6): 532.     CrossRef
Predictive Factors of Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Undergoing Bariatric Surgery
Behrooz Kalidari, Mohsen Mahmoudieh, Hamid Melali, Mehdi Nazari Moghadam, Mohsen Kolahdouzan
Hepatitis Monthly.2017;[Epub]     CrossRef
Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease
Afagh Garjani, Abdolrasoul Safaeiyan, Manouchehr Khoshbaten
Hepatitis Monthly.2015;[Epub]     CrossRef
Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects
Ming Hong, Sha Li, Hor Tan, Ning Wang, Sai-Wah Tsao, Yibin Feng
International Journal of Molecular Sciences.2015; 16(12): 28705.     CrossRef
Hepatic angiogenesis and fibrosis are common features in morbidly obese patients
Monika Ciupińska-Kajor, Marek Hartleb, Maciej Kajor, Michał Kukla, Mariusz Wyleżoł, Dariusz Lange, Łukasz Liszka
Hepatology International.2013; 7(1): 233.     CrossRef
Non-alcoholic fatty liver disease
Ana C. TUYAMA, Charissa Y. CHANG
Journal of Diabetes.2012; 4(3): 266.     CrossRef
Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim
The Korean Journal of Internal Medicine.2012; 27(1): 47.     CrossRef
Inflammation in nonalcoholic steatohepatitis
R Christopher Harmon, Dina G Tiniakos, Curtis K Argo
Expert Review of Gastroenterology & Hepatology.2011; 5(2): 189.     CrossRef
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
Masato Yoneda, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Kento Imajo, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshik
Journal of Gastroenterology.2011; 46(11): 1300.     CrossRef
Nonalcoholic fatty liver disease across ethno-racial groups: Do Asian-American adults represent a new at-risk population?
James H. Tabibian, Mariana Lazo, Francisco A. Durazo, Hsin-Chieh Yeh, Myron J. Tong, Jeanne M. Clark
Journal of Gastroenterology and Hepatology.2011; 26(3): 501.     CrossRef
Sophocarpine alleviates non-alcoholic steatohepatitis in rats
Chun-Yan Song, Xin Zeng, Si-Wen Chen, Ping-Fang Hu, Zhi-Wu Zheng, Bei-Fang Ning, Jian Shi, Wei-Fen Xie, Yue-Xiang Chen
Journal of Gastroenterology and Hepatology.2011; 26(4): 765.     CrossRef
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Curtis K. Argo, Patrick G. Northup, Abdullah M.S. Al-Osaimi, Stephen H. Caldwell
Journal of Hepatology.2009; 51(2): 371.     CrossRef
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Curtis K. Argo, Stephen H. Caldwell
Clinics in Liver Disease.2009; 13(4): 511.     CrossRef
Current status of liver disease in Korea: Nonalcoholic fatty liver disease
Sang Hoon Park
The Korean Journal of Hepatology.2009; 15(Suppl 6): S34.     CrossRef
Predictors of pathological severity in non-alcoholic fatty liver disease: Is East meeting West in the middle?
Edoardo G Giannini, Vincenzo Savarino
Journal of Gastroenterology and Hepatology.2007; 22(4): 461.     CrossRef
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
Thierry Poynard, Vlad Ratziu, Frederic Charlotte, Djamila Messous, Mona Munteanu, Françoise Imbert-Bismut, Julien Massard, Luninita Bonyhay, Mohamed Tahiri, Dominique Thabut, Jean François Cadranel, Brigitte Le Bail, Victor de Ledinghen
BMC Gastroenterology.2006;[Epub]     CrossRef
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
Chun-Jen Liu, Pei-Jer Chen, Yung-Ming Jeng, Wen-Ling Huang, Wei-Shiung Yang, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen
Journal of Hepatology.2005; 43(2): 235.     CrossRef